Cerus reported $47.63M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Atrion ATRI:US 48.88M 8.59M
Cerus CERS:US $ 47.63M 4.61M
Haemonetics HAE:US $ 261.46M 3.54M
Meridian Bioscience VIVO:US $ 67.77M 43.46M
Nuvasive NUVA:US $ 310.45M 19.69M
Orasure Technologies OSUR:US $ 160.46M 92.76M
Quidel QDEL:US $ 613.4M 388.86M
Sientra SIEN:US $ 21.51M 0.12M
Staar Surgical STAA:US $ 81.1M 17.9M
Terumo 4543:JP Y 197340M 17519M
Utah Medical Products UTMD:US $ 13.43M 856K